BioGaia AB (publ) (BIOGY)
BIOGY Stock Price Chart
Explore BioGaia AB (publ) interactive price chart. Choose custom timeframes to analyze BIOGY price movements and trends.
BIOGY Company Profile
Discover essential business fundamentals and corporate details for BioGaia AB (publ) (BIOGY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Jan 2021
Employees
224.00
Website
https://www.biogaia.comCEO
Theresa P. Agnew
Description
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
BIOGY Financial Timeline
Browse a chronological timeline of BioGaia AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 10 Feb 2026
Upcoming earnings on 20 Oct 2025
Earnings released on 18 Jul 2025
EPS came in at $0.87 , while revenue for the quarter reached $404.69M , beating expectations by +16.29%.
Earnings released on 7 May 2025
EPS came in at $0.79 , while revenue for the quarter reached $366.27M .
Dividend declared on 10 Apr 2025
A dividend of $0.71 per share was announced, adjusted to $0.71. The dividend was paid on 29 May 2025.
Earnings released on 12 Feb 2025
EPS came in at $0.81 , while revenue for the quarter reached $364.83M .
Earnings released on 22 Oct 2024
EPS came in at $0.36 , while revenue for the quarter reached $303.97M .
Earnings released on 23 Jul 2024
EPS came in at $1.10 , while revenue for the quarter reached $384.12M .
Dividend declared on 9 May 2024
A dividend of $0.63 per share was announced, adjusted to $0.63. The dividend was paid on 30 May 2024.
Earnings released on 7 May 2024
EPS came in at $1.21 , while revenue for the quarter reached $369.80M .
Earnings released on 7 Feb 2024
EPS came in at $1.01 , while revenue for the quarter reached $317.69M .
Earnings released on 31 Dec 2023
EPS came in at $0.67 , while revenue for the quarter reached $297.77M .
Earnings released on 30 Jun 2023
EPS came in at $0.80 , while revenue for the quarter reached $315.22M .
Dividend declared on 3 May 2023
A dividend of $0.28 per share was announced, adjusted to $0.28. The dividend was paid on 30 May 2023.
Earnings released on 31 Mar 2023
EPS came in at $1.15 , while revenue for the quarter reached $365.82M .
Earnings released on 31 Dec 2022
EPS came in at $1.38 , while revenue for the quarter reached $274.28M .
Earnings released on 30 Sept 2022
EPS came in at $0.79 , while revenue for the quarter reached $257.73M .
Earnings released on 30 Jun 2022
EPS came in at $0.78 , while revenue for the quarter reached $288.09M .
Stock split effective on 26 May 2022
Shares were split 5 : 2 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 4 May 2022
A dividend of $0.59 per share was announced, adjusted to $0.30. The dividend was paid on 31 May 2022.
Earnings released on 31 Mar 2022
EPS came in at $0.76 , while revenue for the quarter reached $283.86M .
Earnings released on 31 Dec 2021
EPS came in at $0.38 , while revenue for the quarter reached $206.16M .
Earnings released on 30 Sept 2021
EPS came in at $0.52 , while revenue for the quarter reached $173.84M .
Earnings released on 30 Jun 2021
EPS came in at $0.54 , while revenue for the quarter reached $203.13M .
Dividend declared on 7 May 2021
A dividend of $0.16 per share was announced, adjusted to $0.08. The dividend was paid on 1 Jun 2021.
Earnings released on 31 Mar 2021
EPS came in at $0.50 , while revenue for the quarter reached $201.98M .
Earnings released on 31 Dec 2020
EPS came in at $0.40 , while revenue for the quarter reached $187.61M .
Earnings released on 30 Sept 2020
EPS came in at $0.23 , while revenue for the quarter reached $131.96M .
BIOGY Stock Performance
Access detailed BIOGY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.